Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Watson/Actavis Merger Requires Near Record Divestiture; Sandoz, Par Pick Up 18 Products

Oct 22 2012

• By Brenda Sandburg

Related Content

Impax Gains Products In Watson Deal With FTC To Finalize Arrow Acquisition

Dec 07 2009

Mylan/Merck KGaA To Divest Five Generic Drugs To Clear Antitrust Hurdle For Acquisition

Sep 27 2007

Novartis' Purchase Of Eon Clears FTC; Amide Gets Three Divested Generics

Jul 19 2005

Hikma To Divest Phenytoin, Promethazine Injectables To Acquire Baxter Business

Apr 27 2011

FTC Clearance Of Watson’s Andrx Acquisition Requires 13 Generic Divestitures

Oct 31 2006

FTC Clears Barr’s Acquisition Of Pliva Based On Divestiture Of Generic Drugs

Oct 23 2006

Par Gets Pumped: Teva To Divest $200 Million Of Products To Acquire Cephalon

Oct 11 2011

Teva/Ivax Merger Gets FTC OK Pending Divestitures

Jan 23 2006

Sun Clears FTC Hurdle For Taro Acquisition; Sells Carbamezapine To Fellow Indian Co. Torrent

Aug 14 2008

Related Companies

Allergan plc

Allergan plc

Teva Pharmaceutical Industries Ltd.

Barr Pharmaceuticals

Endo, Inc.

Par Pharmaceutical Companies Inc.

Novartis AG

Novartis AG

GSK plc

Bausch Health Companies Inc.

Johnson & Johnson

Purdue Pharma L.P.

Additional Topics

Regulation BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window